We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Short Communication

Inhibition of histone deacetylases stimulates HBV replication independent of protein X

    Maarten AA van de Klundert

    Department of Blood-borne Infections, Sanquin, Amsterdam, The Netherlands

    Department of Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands

    ,
    Marjolein Swart

    Department of Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands

    ,
    Hans L Zaaijer

    Department of Blood-borne Infections, Sanquin, Amsterdam, The Netherlands

    Laboratory of Clinical Virology of the Department of Medical Microbiology, Center for Infection & Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Authors contributed equally

    Search for more papers by this author

    &
    Neeltje A Kootstra

    *Author for correspondence:

    E-mail Address: n.a.kootstra@amc.uva.nl

    Department of Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands

    Authors contributed equally

    Search for more papers by this author

    Published Online:https://doi.org/10.2217/fvl.15.22

    ABSTRACT 

    Aim: HBV expresses an accessory protein called X (HBx), which supports HBV replication by increasing transcription from episomal templates. Here, we investigate whether HBx augments HBV replication by interfering with the deacetylation of HBV DNA associated histones by histone deacetylases (HDACs). Materials & methods: To study the effect of HBx on episomal transcription, we transfected HEK 293 cells with luciferase-expressing constructs together with HBx in the presence and absence of HDAC inhibitors. We confirmed our results in the context of the full HBV replication cycle in HepG2 cells. Results & conclusion: Inhibition of HDAC activity and HBx expression stimulated transcription from episomal DNA independently, showing that HBx does not affect the histone deacetylation. HDAC inhibitors also augmented HBV replication in vitro independent of HBx expression. This suggests that treatment with HDAC inhibitors can (re)activate HBV infection in patients with cleared or ongoing HBV infection.

    References

    • 1 Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J. Hepatol. 51(3), 581–592 (2009).
    • 2 Pollicino T, Belloni L, Raffa G et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 130(3), 823–837 (2006).
    • 3 Luo L, Chen S, Gong Q et al. Hepatitis B virus X protein modulates remodelling of minichromosomes related to hepatitis B virus replication in HepG2 cells. Int. J. Mol. Med. 31(1), 197–204 (2013).
    • 4 Keasler VV, Hodgson AJ, Madden CR, Slagle BL. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J. Virol. 81(6), 2656–2662 (2007).
    • 5 Colgrove R, Simon G, Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J. Virol. 63(9), 4019–4026 (1989).
    • 6 Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J. Virol. 78(23), 12725–12734 (2004).
    • 7 Tang H, Oishi N, Kaneko S, Murakami S. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci. 97(10), 977–983 (2006).
    • 8 Wei Y, Neuveut C, Tiollais P, Buendia MA. Molecular biology of the hepatitis B virus and role of the X gene. Pathol. Biol. (Paris) 58(4), 267–272 (2010).
    • 9 van Breugel PC, Robert EI, Mueller H et al. Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates. Hepatology 56(6), 2116–2124 (2012).
    • 10 Tang H, Delgermaa L, Huang F et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J. Virol. 79(9), 5548–5556 (2005).
    • 11 Belloni L, Pollicino T, De NF et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc. Natl. Acad. Sci. USA 106(47), 19975–19979 (2009).
    • 12 Belloni L, Allweiss L, Guerrieri F et al. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J. Clin. Invest. 122(2), 529–537 (2012).
    • 13 Ren JH, Tao Y, Zhang ZZ et al. Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1. J. Virol. 88(5), 2442–2451 (2014).
    • 14 Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A 84(4), 1005–1009 (1987).
    • 15 van de Klundert MA, van Hemert FJ, Zaaijer HL, Kootstra NA. The hepatitis B virus x protein inhibits thymine DNA glycosylase initiated base excision repair. PLoS ONE. 7(11), e48940 (2012).
    • 16 Baumert TF, Rogers SA, Hasegawa K, Liang TJ. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J. Clin. Invest 98(10), 2268–2276 (1996).
    • 17 Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de BM, Verhoef K, Berkhout B. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J. Virol. 74(8), 3740–3751 (2000).
    • 18 Bol SM, Booiman T, Bunnik EM et al. Polymorphism in HIV-1 dependency factor PDE8A affects mRNA level and HIV-1 replication in primary macrophages. Virology 420(1), 32–42 (2011).
    • 19 Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209(4455), 497–499 (1980).
    • 20 Ritchie D, Piekarz RL, Blombery P et al. Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report. Haematologica 94(11), 1618–1622 (2009).